XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)
6 Months Ended
Jun. 30, 2021
REVENUE RECOGNITION AND RELATED ALLOWANCES  
Schedule of disaggregation of revenue and revenue recognized

Three Months Ended

Six Months Ended

Products and Services

June 30, 

June 30, 

June 30, 

June 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

    

Sales of generic pharmaceutical products

$

34,199

$

33,400

$

66,812

$

70,895

Sales of branded pharmaceutical products

 

11,038

 

10,633

 

18,555

 

19,790

Sales of contract manufactured products

 

2,322

 

2,900

 

4,895

 

4,874

Royalties from licensing agreements

 

 

491

 

11,210

 

781

Product development services

 

97

 

885

 

255

 

1,462

Other

 

969

 

161

 

1,419

 

442

Total net revenues

$

48,625

$

48,470

$

103,146

$

98,244

Three Months Ended

Six Months Ended

Timing of Revenue Recognition

June 30, 

June 30, 

June 30, 

June 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

    

Performance obligations transferred at a point in time

$

48,528

$

47,585

$

102,891

$

96,782

Performance obligations transferred over time

 

97

 

885

 

255

 

1,462

Total

$

48,625

$

48,470

$

103,146

$

98,244

Schedule of accruals and allowances

The following table summarizes activity in the consolidated balance sheets for accruals and allowances for the six months ended June 30, 2021 and 2020, respectively:

Accruals for Chargebacks, Returns, and Other Allowances

Administrative

Prompt

Government

Fees and Other

Payment

(in thousands)

    

Chargebacks

    

Rebates

    

Returns

    

Rebates

    

Discounts

Balance at December 31, 2019 (1)

$

49,882

$

8,901

$

16,595

$

8,281

$

2,549

Accruals/Adjustments

 

181,986

 

7,519

 

14,103

 

17,392

 

6,551

Credits Taken Against Reserve

 

(169,345)

(6,703)

 

(10,695)

 

(17,161)

 

(6,277)

Balance at June 30, 2020 (1)

$

62,523

$

9,717

$

20,003

$

8,512

$

2,823

Balance at December 31, 2020 (1)

$

88,746

$

7,826

$

27,155

$

8,906

$

3,839

Accruals/Adjustments

 

214,125

 

12,980

 

21,058

 

32,207

 

13,315

Credits Taken Against Reserve

 

(220,776)

(12,066)

 

(16,309)

 

(33,071)

 

(13,682)

Balance at June 30, 2021 (1)

$

82,095

$

8,740

$

31,904

$

8,042

$

3,472

(1)Chargebacks are included as an offset to accounts receivable in the unaudited condensed consolidated balance sheets. Administrative Fees and Other Rebates and Prompt Payment Discounts are included as an offset to accounts receivable or as accrued expenses and other in the unaudited condensed consolidated balance sheets. Returns are included in returned goods reserve in the unaudited condensed consolidated balance sheets. Government Rebates are included in accrued government rebates in the unaudited condensed consolidated balance sheets.
Schedule of customer concentration

Three Months Ended

Six Months Ended

June 30, 

June 30, 

June 30, 

June 30, 

    

2021

    

2020

    

2021

    

    

2020

    

Customer 1

34

%

33

%

29

%

32

%

Customer 2

26

%

22

%

22

%

23

%

Customer 3

14

%

19

%

14

%

19

%